Since activated Ras can stimulate ERK1/2 in many cancer types[28], we hypothesized that the Ras-GTPase inhibitor may block activation of ERK1/2 and expression of EGR1 and Snail in Tβ10-silenced CCA cell lines. Here, MAPK3 is linked to cholangiocarcinoma.